Trial
NCT02486510
Effect of Cytoreductive Chemotherapy and a CCR5 Coreceptor Antagonist on HIV-1 Eradication
Early Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Collaborators
—
Condition
HIV-1 Infection
Intervention
Maraviroc
Why stopped
Futility criteria
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-18